Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide PM Zygmunt, J Petersson, DA Andersson, H Chuang, M Sorgard, ... Nature 400 (6743), 452-456, 1999 | 2594 | 1999 |
The endogenous cannabinoid system controls extinction of aversive memories G Marsicano, CT Wotjak, SC Azad, T Bisogno, G Rammes, MG Cascio, ... Nature 418 (6897), 530-534, 2002 | 2103 | 2002 |
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2 RG Pertwee, AC Howlett, ME Abood, SPH Alexander, V Di Marzo, ... Pharmacological reviews 62 (4), 588-631, 2010 | 2047 | 2010 |
Formation and inactivation of endogenous cannabinoid anandamide in central neurons V Di Marzo, A Fontana, H Cadas, S Schinelli, G Cimino, JC Schwartz, ... Nature 372 (6507), 686-691, 1994 | 2035 | 1994 |
Leptin-regulated endocannabinoids are involved in maintaining food intake V Di Marzo, SK Goparaju, L Wang, J Liu, S Bátkai, Z Járai, F Fezza, ... Nature 410 (6830), 822-825, 2001 | 2023 | 2001 |
Identification and functional characterization of brainstem cannabinoid CB2 receptors MD Van Sickle, M Duncan, PJ Kingsley, A Mouihate, P Urbani, K Mackie, ... Science 310 (5746), 329-332, 2005 | 1903 | 2005 |
The endocannabinoid system and its therapeutic exploitation VD Marzo, M Bifulco, LD Petrocellis Nature reviews Drug discovery 3 (9), 771-784, 2004 | 1500 | 2004 |
CB1 cannabinoid receptors and on-demand defense against excitotoxicity G Marsicano, S Goodenough, K Monory, H Hermann, M Eder, A Cannich, ... Science 302 (5642), 84-88, 2003 | 1431 | 2003 |
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide T Bisogno, L Hanuš, L De Petrocellis, S Tchilibon, DE Ponde, I Brandi, ... British journal of pharmacology 134 (4), 845-852, 2001 | 1397 | 2001 |
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors SM Huang, T Bisogno, M Trevisani, A Al-Hayani, L De Petrocellis, F Fezza, ... Proceedings of the National Academy of Sciences 99 (12), 8400-8405, 2002 | 1238 | 2002 |
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain T Bisogno, F Howell, G Williams, A Minassi, MG Cascio, A Ligresti, ... The Journal of cell biology 163 (3), 463-468, 2003 | 1213 | 2003 |
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders O Devinsky, MR Cilio, H Cross, J Fernandez‐Ruiz, J French, C Hill, ... Epilepsia 55 (6), 791-802, 2014 | 1182 | 2014 |
Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes L De Petrocellis, A Ligresti, AS Moriello, M Allarŕ, T Bisogno, S Petrosino, ... British journal of pharmacology 163 (7), 1479-1494, 2011 | 1092 | 2011 |
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb AA Izzo, F Borrelli, R Capasso, V Di Marzo, R Mechoulam Trends in pharmacological sciences 30 (10), 515-527, 2009 | 1085 | 2009 |
Endocannabinoid control of food intake and energy balance V Di Marzo, I Matias Nature neuroscience 8 (5), 585-589, 2005 | 1048 | 2005 |
Targeting the endocannabinoid system: to enhance or reduce? V Di Marzo Nature reviews Drug discovery 7 (5), 438-455, 2008 | 1019 | 2008 |
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action V Di Marzo, D Melck, T Bisogno, L De Petrocellis Trends in neurosciences 21 (12), 521-528, 1998 | 1015 | 1998 |
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol TC Kirkham, CM Williams, F Fezza, VD Marzo British journal of pharmacology 136 (4), 550-557, 2002 | 980 | 2002 |
Cannabinoids and the expanded endocannabinoid system in neurological disorders L Cristino, T Bisogno, V Di Marzo Nature Reviews Neurology 16 (1), 9-29, 2020 | 855 | 2020 |
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity S Ben-Shabat, E Fride, T Sheskin, T Tamiri, MH Rhee, Z Vogel, T Bisogno, ... European journal of pharmacology 353 (1), 23-31, 1998 | 781 | 1998 |